Botulinum Toxin Type A for Poststroke Cricopharyngeal Muscle Dysfunction

Archives of Physical Medicine and Rehabilitation

Volumn 87, Issue 10, 2006, Pages 1346-1351

  Kim, Deog Young ^a   Park, Chang il ^a   Ohn, Suk Hoon ^a   Moon, Ja Young ^a   Chang, Won Hyuk ^a   Park, Seung woo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Botulinum toxin type A; Dysphagia; Pharyngeal muscles; Rehabilitation; Stroke

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRICOPHARYNGEUS MUSCLE; DISABILITY; DYSPHAGIA; ENDOSCOPE; FEMALE; FLUOROSCOPY; HUMAN; MALE; MANOMETRY; PHARYNX DISEASE; RATING SCALE; SCORING SYSTEM; STROKE PATIENT; SYSTEMIC DISEASE; THERAPY EFFECT; UNIVERSITY HOSPITAL; UPPER ESOPHAGUS SPHINCTER; VOCAL CORD PARALYSIS;

AGED; BOTULINUM TOXIN TYPE A; CEREBROVASCULAR ACCIDENT; ESOPHAGEAL SPHINCTER, UPPER; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCULAR DISEASES; NEUROMUSCULAR AGENTS;

EID: 33749127202     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2006.06.018     Document Type: Article

References (26)

1. Horner J., Massey E.W., and Brazer S.R. Aspiration in bilateral stroke patients: a validation study. Neurology 43 (1993) 430-433
2. Veis S.L., and Logemann J.A. Swallowing disorders in persons with cerebrovascular accident. Arch Phys Med Rehabil 66 (1985) 372-375
3. Cruse J.P., Edwards D.A., Smith J.F., and Wyllie J.H. The pathology of cricopharyngeal dysphagia. Histopathology 3 (1972) 223-232
4. Baredes S., Shah C.S., and Kaufman R. The frequency of cricopharyngeal dysfunction on videofluoroscopic swallowing studies in patients with dysphagia. Am J Otol 18 (1997) 185-189
5. Ellis Jr. F.H., and Crozier R.E. Cervical esophageal dysphagia: indications for and results of cricopharyngeal myotomy. Ann Surg 194 (1981) 279-289
6. Ross E.R., Green R., Auslander M.O., and Biller H.F. Cricopharyngeal myotomy: management of cervical dysphagia. Otolaryngol Head Neck Surg 90 (1982) 434-441
7. Van den Bergh P., Francart J., Mourin S., Kollmann P., and Laterre E.C. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 18 (1995) 720-729
8. Borodic G.E., Joseph M., Fay L., Cozzolino D., and Ferrante R.J. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck 12 (1990) 392-399
9. Blitzer A., Brin M.F., Fahn S., and Lovelace R.E. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 98 (1988) 193-197
10. Graham H.K., Aoki K.R., Autti-Ramo I., et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 11 (2000) 67-79
11. Schneider I., Thumfart W.F., Pototschnig C., and Eckel H.E. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol 103 (1994) 31-35
12. Blitzer A., and Mitchell F.B. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg 116 (1997) 328-330
13. Haapaniemi J.J., Laurikainen E.A., Pulkkinen J., and Marttila R.J. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia 16 (2001) 171-175
14. Ahsan S.F., Meleca R.J., and Dworkin J.P. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg 122 (2000) 691-695
15. Alberty J., Oelerich M., Ludwig K., Hartmann S., and Stoll W. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope 110 (2000) 1151-1156
16. Shaw G.Y., and Searl J.P. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia 16 (2001) 161-167
17. Murry T., Wasserman T., Carrau R.L., and Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol 26 (2005) 157-162
18. Han T.R., Paik N.J., and Park J.W. Quantifying swallowing function after stroke: a functional dysphagia scale based on videofluoroscopic studies. Arch Phys Med Rehabil 82 (2001) 677-682
19. McConnel F.M., Cerenko D., Jackson R.T., and Guffin Jr. T.N. Timing of major events of pharyngeal swallowing. Arch Otolaryngol Head Neck Surg 114 (1988) 1413-1418
20. Sonies B.C., and Baum B.J. Evaluation of swallowing pathophysiology. Otolaryngol Clin North Am 21 (1988) 637-648
21. Brant C.Q., Siqueira E.S., and Ferrari Jr. A.P. Botulinum toxin for oropharyngeal dysphagia: case report of flexible endoscope-guided injection. Dis Esophagus 12 (1999) 68-73
22. Kelly J.H. Use of manometry in the evaluation of dysphagia. Otolaryngol Head Neck Surg 116 (1997) 355-357
23. Pasricha P.J., Ravich W.J., Hendrix T.R., Sostre S., Jones B., and Kalloo A.N. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 121 (1994) 590-591
24. Pasricha P.J., Ravich W.J., and Hendrix T.R. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332 (1995) 774-778
25. Pasricha P.J., Rai R., Ravich W.J., Hendrix T.R., and Kalloo A.N. Botulinum toxin for achalasia: long term outcome and predictors of response. Gastroenterology 110 (1996) 1410-1415
26. Ferrari A.P., Siqueira E.S., and Brant C.Q. Treatment of achalasia in Chagas' disease with botulinum toxin. N Engl J Med 332 (1995) 834-835